AI-gestuurde fenotypisering van HFpEF onthult vroege en late ziektestadia — EHR-cohortstudie
In een cohort van 2223 patiënten met hartfalen met behoud van ejectiefractie (HFpEF) identificeerde een AI-gestuurde analyse van elektronische patiëntendossiers vier herhaalbare fenotypen: jong met weinig comorbiditeit, obesitas-gerelateerd, ouderen met atriale dysfunctie en cardiovasculair-nier-metabool (C-K-M). Patiënten in het C-K-M-fenotype hadden het hoogste sterfterisico (HR 1,53), terwijl het fenotype 'jong met weinig comorbiditeit' het meest dynamisch was en vaak overging in een meer gevorderd stadium. Deze longitudinale fenotypisering kan cardiologen helpen om HFpEF-patiënten eerder te stratificeren en mogelijk modificeerbare vroege ziektestadia te herkennen voor gerichte therapie.
Abstract (original)
BACKGROUND AND AIMS: Heart failure with preserved ejection fraction (HFpEF) phenotypes have been characterised as static entities in trial populations yet their temporal dynamics remain unexplored in routine clinical practice. We aimed to identify HFpEF phenogroups from real-world electronic health records (EHRs), characterise their longitudinal stability and determine whether phenogroup trajectories were associated with differences in mortality. METHODS: A natural language processing (NLP) pipeline identified HFpEF cases from multisite EHRs (2010-2022). Latent class analysis (LCA) defined baseline phenogroups and annual supervised random forest (RF) classification using time-updated values of the same baseline LCA variables tracked individual transitions over five years. Competing risks regression quantified transition versus death probabilities. Time-varying Cox models assessed mortality risk associated with current (vs baseline) phenogroup status. Phenogroups were independently re-derived by LCA in an external cohort and compared with RF predictions. RESULTS: Among 2223 patients (60% female, median age 75 years (IQR 63-83); left ventricular ejection fraction (LVEF) 60.1%; follow-up 4.0 years (IQR 2.2-6.1), we identified four phenogroups: young-low comorbidity (22%), obesity-predominant (24%), elderly atrial dysfunction (32%) and cardiovascular-kidney-metabolic (23%). Young-low comorbidity had the highest transition probability (47.7%), while cardiovascular-kidney-metabolic and elderly-atrial dysfunction were highly stable (3.2% and 12.1% transitioned, respectively). Within young-low comorbidity, those who transitioned had greater baseline cardiac abnormalities, including higher E/e', left ventricle mass and wall thickness. Adjusted mortality risk was highest in cardiovascular-kidney-metabolic (HR 1.53, 95% CI 1.22 to 1.92, p<0.001); current phenogroup status discriminated mortality risk modestly better than baseline classification alone (C-index 0.659 vs 0.648). In an independent external cohort (n=3349), RF predictions agreed strongly with independently derived LCA phenogroup labels (C-statistics 0.891-0.953). CONCLUSION: Longitudinal NLP-based phenotyping of real-world EHRs identified four reproducible HFpEF phenogroups with distinct trajectories, distinguishing an early progressive disease state from stable advanced phenotypes. Earlier HFpEF detection using artificial intelligence-driven EHR tools could facilitate phenotype-targeted treatment of patients at potentially modifiable stages.
Dit artikel is een samenvatting van een publicatie in Open heart. Voor het volledige artikel, alle details en referenties verwijzen wij u naar de oorspronkelijke bron.
Lees het volledige artikelDOI: 10.1136/openhrt-2026-004351
Wilt u op de hoogte blijven?
Gratis: de maandelijkse nieuwsbrief met het nieuwsoverzicht, en de site afgestemd op uw vakgebied.
